[{"address1": "301 Binney Street", "address2": "3rd Floor", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "857 259 3860", "website": "https://www.scholarrock.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Its transforming growth factor beta (TGF\u00df) superfamily biology, its novel understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for development of monoclonal antibodies that locally and selectively target the precursor. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.", "fullTimeEmployees": 128, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jay Thomas Backstrom M.D., M.P.H.", "age": 68, "title": "President, CEO & Director", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 1071673, "exercisedValue": 0, "unexercisedValue": 3439375}, {"maxAge": 1, "name": "Mr. Edward H. Myles MBA", "age": 52, "title": "Senior Advisor", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 720786, "exercisedValue": 0, "unexercisedValue": 857292}, {"maxAge": 1, "name": "Ms. Tracey M. Sacco M.B.A.", "age": 48, "title": "Chief Commercial Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 548855, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan  Iarrobino", "title": "Senior Vice President of Clinical Development & Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jing L. Marantz M.B.A., M.D., Ph.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beth  Shafer Ph.D.", "title": "Chief Business Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  Wyman", "title": "Chief Technical & Quality Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 9, "overallRisk": 8, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 33.36, "open": 33.42, "dayLow": 32.03, "dayHigh": 33.93, "regularMarketPreviousClose": 33.36, "regularMarketOpen": 33.42, "regularMarketDayLow": 32.03, "regularMarketDayHigh": 33.93, "payoutRatio": 0.0, "beta": 0.603, "forwardPE": -15.274418, "volume": 979310, "regularMarketVolume": 774490, "averageVolume": 967014, "averageVolume10days": 1301570, "averageDailyVolume10Day": 1301570, "bid": 32.68, "ask": 32.95, "bidSize": 1, "askSize": 1, "marketCap": 3109186048, "fiftyTwoWeekLow": 6.76, "fiftyTwoWeekHigh": 46.98, "fiftyDayAverage": 37.8743, "twoHundredDayAverage": 25.175776, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2737032960, "profitMargins": 0.0, "floatShares": 69786242, "sharesOutstanding": 94676800, "sharesShort": 16131337, "sharesShortPriorMonth": 15982742, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.17040001, "heldPercentInsiders": 0.01276, "heldPercentInstitutions": 1.16685, "shortRatio": 19.34, "shortPercentOfFloat": 0.3123, "impliedSharesOutstanding": 94676800, "bookValue": 3.929, "priceToBook": 8.358361, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -246294000, "trailingEps": -2.47, "forwardEps": -2.15, "enterpriseToEbitda": -10.943, "52WeekChange": 0.9559262, "SandP52WeekChange": 0.06429911, "quoteType": "EQUITY", "currentPrice": 32.84, "targetHighPrice": 57.0, "targetLowPrice": 45.0, "targetMeanPrice": 50.5, "targetMedianPrice": 50.0, "recommendationMean": 1.44444, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 437278016, "totalCashPerShare": 4.619, "ebitda": -250116992, "totalDebt": 65126000, "quickRatio": 9.362, "currentRatio": 9.612, "debtToEquity": 17.667, "returnOnAssets": -0.40087003, "returnOnEquity": -0.82948, "grossProfits": -184550000, "freeCashflow": -111554872, "operatingCashflow": -200948992, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SRRK", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1743192308, "regularMarketTime": 1743192000, "exchange": "NMS", "messageBoardId": "finmb_548810128", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Scholar Rock Holding Corporatio", "longName": "Scholar Rock Holding Corporation", "marketState": "CLOSED", "regularMarketChangePercent": -1.5587543, "regularMarketPrice": 32.84, "epsTrailingTwelveMonths": -2.47, "epsForward": -2.15, "epsCurrentYear": -2.62386, "priceEpsCurrentYear": -12.515912, "fiftyDayAverageChange": -5.034298, "fiftyDayAverageChangePercent": -0.13292122, "twoHundredDayAverageChange": 7.6642246, "twoHundredDayAverageChangePercent": 0.30442855, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1527255000000, "postMarketChangePercent": 0.0, "postMarketPrice": 32.84, "postMarketChange": 0.0, "regularMarketChange": -0.52000046, "regularMarketDayRange": "32.03 - 33.93", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 967014, "fiftyTwoWeekLowChange": 26.08, "fiftyTwoWeekLowChangePercent": 3.857988, "fiftyTwoWeekRange": "6.76 - 46.98", "fiftyTwoWeekHighChange": -14.139999, "fiftyTwoWeekHighChangePercent": -0.30097914, "fiftyTwoWeekChangePercent": 95.59262, "earningsTimestamp": 1740657600, "earningsTimestampStart": 1746448200, "earningsTimestampEnd": 1746793800, "earningsCallTimestampStart": 1740662100, "earningsCallTimestampEnd": 1740662100, "isEarningsDateEstimate": true, "displayName": "Scholar Rock Holding", "trailingPegRatio": null, "__fetch_time": "2025-03-29"}]